Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2017-09-19FDA Approved: DONEPEZIL HYDROCHLORIDE — Original Application (Cadila Pharmaceuticals Limited)
FDA approves Cadila Pharmaceuticals' original application for a generic donepezil hydrochloride product for the treatment of Alzheimer's dis…
-
CLINICAL_TRIALS trial_result · 2017-09-05Clinical Trial Update: Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy In Subjects With Mild To Moderate Alzheimer's Disease [Phase 3]
Phase 3 trial of rosiglitazone extended-release as adjunctive therapy in mild-to-moderate Alzheimer's disease completed.
-
CLINICAL_TRIALS trial_result · 2017-09-01Clinical Trial Update: Repetitive Transcranial Magnetic Stimulation in Patients With Alzheimer Disease [NA]
Clinical trial update on repetitive transcranial magnetic stimulation for patients with Alzheimer's disease.
-
CLINICAL_TRIALS trial_result · 2017-08-28Clinical Trial Update: Effectiveness of Care Management in Alzheimer Patients [NA]
A completed clinical trial evaluating the effectiveness of care management in patients with Alzheimer's disease and mild to moderately sever…
-
CLINICAL_TRIALS research · 2017-08-23Clinical Trial Update: Co-LEsions in Alzheimer Disease and Related Disorders [NA]
This clinical trial update notes co-lesions in Alzheimer's disease and related disorders, including Lewy body disease and cerebrovascular di…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-08-14Clinical Trial Update: Efficacy and Safety of Ramelteon in Subjects With Mild to Moderate Alzheimer's Disease [Phase 2]
A Phase 2 trial update evaluating the efficacy and safety of ramelteon in subjects with mild to moderate Alzheimer's disease.
-
CLINICAL_TRIALS trial_result · 2017-08-14Clinical Trial Update: The Cognitive Resilience Study [NA]
Duke University's Cognitive Resilience Study for Alzheimer disease has completed.
-
CLINICAL_TRIALS withdrawal · 2017-08-09Clinical Trial Update: CPC-201 Alzheimer's Disease Type Dementia: PET Study [Phase 2]
The Phase 2 Alzheimer's disease PET study CPC-201 has been withdrawn. Sponsor is Chase Pharmaceuticals Corporation, an affiliate of Allergan…
-
CLINICAL_TRIALS trial_result · 2017-08-09Clinical Trial Update: Development of a New Neuroimaging Method Aimed to Differentiate Mnesic Abilities of Alzheimer and Depressed Patients [NA]
This document reports an update on a clinical trial developing a neuroimaging method to differentiate memory abilities in patients with Alzh…
-
CLINICAL_TRIALS trial_result · 2017-08-09Clinical Trial Update: Evaluation of the Animal Intervention Used as Therapy [NA]
Clinical trial evaluating an animal-based intervention as therapy for Alzheimer disease; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2017-08-07Clinical Trial Update: A Study To Demonstrate The Bioequivalence Of Rosiglitazone XR (BRL-049653) 8mgs XR Manufactured At Two Different Sites. [Phase 1]
This Phase 1 trial demonstrates the bioequivalence of Rosiglitazone XR 8 mg extended-release capsules manufactured at two different sites, a…
-
FDA approval · 2017-08-03FDA Approved: MEMANTINE HYDROCHLORIDE — Original Application (Zydus Lifesciences Limited)
FDA approved memantine hydrochloride as an original generic application by Zydus Lifesciences Limited. The approval covers memantine hydroch…
-
CLINICAL_TRIALS trial_result · 2017-08-02Clinical Trial Update: Brain-Computer Interface System for Training Memory and Attention in Elderly [Phase 2]
Phase 2 clinical trial update on a brain-computer interface system designed to train memory and attention in older adults at risk for Alzhei…
-
CLINICAL_TRIALS trial_result · 2017-08-01Clinical Trial Update: Randomized Trial of Low-dose Naproxen in Cognitively Intact Persons at Risk of Alzheimer's Dementia [Phase 2]
A Phase 2 randomized trial tested low-dose naproxen in cognitively intact individuals at risk for Alzheimer's dementia; the study has comple…
-
CLINICAL_TRIALS trial_result · 2017-08-01Clinical Trial Update: Computerized Cognition Testing in Participants With Mild Alzheimer's Disease (AD) Treated With Donepezil (MK-0000-318) [Phase 2]
Phase 2 trial update evaluating computerized cognition testing in participants with mild Alzheimer's disease treated with donepezil (MK-0000…
-
CLINICAL_TRIALS trial_result · 2017-07-31Clinical Trial Update: OmegAD (Omega-3 and Alzheimer's Disease) [NA]
This entry notes that the OmegAD study evaluating omega-3 fatty acids for Alzheimer's disease has completed enrollment/status, with no furth…
-
CLINICAL_TRIALS research · 2017-07-31Clinical Trial Update: Eye Movement Recording as an Early Differential Diagnostic Tool for Alzheimer/Depression [NA]
This clinical trial update describes using eye movement recording as an early differential diagnostic tool to distinguish between Alzheimer’…
-
CLINICAL_TRIALS trial_result · 2017-07-28Clinical Trial Update: Effects of Simvastatin on Biomarkers [Phase 4]
Phase 4 clinical trial evaluating the effects of simvastatin on biomarkers in Alzheimer's disease has completed and results are posted.
-
CLINICAL_TRIALS trial_result · 2017-07-26Clinical Trial Update: A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Beta-Amyloid When Compared With Postmortem Histopathology [Phase 3]
A Phase 3 clinical trial evaluating the efficacy and safety of the PET tracer [18F]NAV4694 for detecting cerebral beta-amyloid, using postmo…
-
CLINICAL_TRIALS trial_result · 2017-07-25Clinical Trial Update: Clinical Pathway for Alzheimer's Disease in China (CPAD)
This update notes that the CPAD (Clinical Pathway for Alzheimer's Disease in China) trial conducted by Peking University has completed.
-
CLINICAL_TRIALS trial_result · 2017-07-21Clinical Trial Update: PK, Dose Proportionality, Food Effect And Repeat Dose Study Of Rosiglitazone XR In Healthy Volunteers [Phase 1]
Phase 1 study evaluating the pharmacokinetics, dose proportionality, food effect and repeat-dose safety of rosiglitazone XR in healthy volun…
-
CLINICAL_TRIALS trial_result · 2017-07-21Clinical Trial Update: A Clinical Study to Assess Single and Repeat Doses of a New Medication (GSK933776) in Patients With Alzheimer's Disease [Phase 1]
A Phase 1 clinical study evaluating single and repeat dosing of GSK933776 in patients with Alzheimer's disease. The trial, sponsored by Glax…
-
CLINICAL_TRIALS trial_result · 2017-07-21Clinical Trial Update: A Study of RO7105705 in Healthy Participants and Participants With Mild-to-Moderate Alzheimer's Disease [Phase 1]
A Phase 1 study evaluated RO7105705 in healthy participants and in individuals with mild-to-moderate Alzheimer's disease; the trial has comp…
-
CLINICAL_TRIALS research · 2017-07-13Clinical Trial Update: Validation of a Scale of Well-Being Assessment (SIWA) in Patients With Alzheimer's Disease or a Related Disease.
Termination update for a clinical trial validating the SIWA well-being scale in patients with Alzheimer's disease.
-
CLINICAL_TRIALS trial_result · 2017-07-12Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of MABT5102A in Patients With Mild to Moderate Alzheimer's Disease (ABBY) [Phase 2]
Phase 2 study evaluating the efficacy and safety of MABT5102A in patients with Alzheimer's disease has completed.